New standard for diabetes care: tighter control urged Gill Higgins Newsletter Article 15 February 2013 Pages: 3 - 4
Flosequinan withdrawal based on commercial, not medical, interests Newsletter Article 15 February 2013 Pages: 6 - 6
Growth hormone: potential uses in the elderly Martin Harris Newsletter Article 15 February 2013 Pages: 7 - 7
Brief cardiac rehabilitation may be economically justified Newsletter Article 15 February 2013 Pages: 8 - 8
Cost savings follow conversion from glipizide to glibenclamide Newsletter Article 15 February 2013 Pages: 9 - 9
D2-agonist a partial answer for negative schizophrenic symptoms Newsletter Article 15 February 2013 Pages: 10 - 10
TA-383 demonstrates potential in rheumatoid arthritis Newsletter Article 15 February 2013 Pages: 10 - 10
Aminoguanidine attractive for patients with diabetes Newsletter Article 15 February 2013 Pages: 11 - 11
Combination therapy not the answer to zidovudine resistance Newsletter Article 15 February 2013 Pages: 13 - 13
Addition of theophylline in COPD gives little value Newsletter Article 15 February 2013 Pages: 13 - 13
Diltiazem may be more suitable in physically active hypertensives Newsletter Article 15 February 2013 Pages: 13 - 13
Prophylaxis useful for pentamidineinduced bronchospasm Newsletter Article 15 February 2013 Pages: 14 - 14
New macrolide active against Haemophilus influenzae Newsletter Article 15 February 2013 Pages: 14 - 14
PEG-SOD offers new hope for patients with severe head injury Jill Stein Newsletter Article 15 February 2013 Pages: 15 - 15
Similar survival with adjuvant therapies in oesophageal cancer Newsletter Article 15 February 2013 Pages: 15 - 15
Combinations of thrombolytics in MI - the way forward? Newsletter Article 15 February 2013 Pages: 17 - 17
Can aspirin and NSAIDs reduce colorectal cancer risk? Newsletter Article 15 February 2013 Pages: 18 - 18